Farhad Ghorbani | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Farhad Ghorbani | Cancer Cell Biology | Best Researcher Award

Assist. Prof. Dr. Farhad Ghorbani | Shiraz University of Medical Sciences ,Shiraz,Iran | Iran

Dr. Farhad Ghorbani is an esteemed Assistant Professor of Oral and Maxillofacial Surgery at Shiraz University of Medical Sciences, Iran. With over two decades of clinical and academic experience, he has significantly contributed to the fields of oral pathology, trauma, and surgical interventions. A graduate of Kerman University of Medical Sciences, Dr. Ghorbani later specialized further at Shiraz University. His dedication to advancing clinical knowledge is reflected in over a dozen high-impact peer-reviewed publications, focusing on craniofacial abnormalities, surgical outcomes, and rare oral diseases. He is an active researcher with a Scopus Author ID and ORCID, consistently contributing to scientific journals like BMC Oral Health, Scientific Reports, and Maxillofacial Plastic and Reconstructive Surgery. His multidisciplinary collaborations have led to enhanced diagnostic techniques and patient outcomes. Dr. Ghorbani is recognized for both his innovative research and his commitment to medical education.

Publication Profile: 

Orcid

Google Scholar

Education:

Dr. Ghorbani began his medical journey at Kerman University of Medical Sciences, earning his professional doctorate in dentistry (1992–1998). Following years of clinical practice, he advanced his academic and surgical expertise by joining Shiraz University of Medical Sciences in 2013, where he underwent specialized training in Oral and Maxillofacial Surgery and served as an Assistant Professor during his educational tenure (2013–2018). His academic training focused on maxillofacial pathology, surgical techniques, and interdisciplinary diagnostics. The combination of strong foundational medical education and advanced surgical specialization has equipped him with both the theoretical depth and clinical acumen to lead impactful research. His training underlines a commitment to academic excellence and lifelong learning, which is further reflected in his scholarly contributions. Dr. Ghorbani’s educational background bridges foundational dental sciences with advanced surgical innovation.

Experience:

Since December 2018, Dr. Farhad Ghorbani has held the position of Assistant Professor of Oral and Maxillofacial Surgery at Shiraz University of Medical Sciences, Iran. His career blends clinical practice, research, and teaching. Over the years, he has led numerous studies exploring craniofacial morphology, surgical outcomes, dental trauma, and maxillofacial pathologies. He mentors postgraduate students and collaborates with interdisciplinary teams, enhancing diagnostic accuracy and surgical care. His work in both rural and urban settings has exposed him to a wide spectrum of maxillofacial cases, enriching his clinical insights. He actively contributes to improving surgical protocols and patient care standards. Dr. Ghorbani’s experience also includes academic publishing, peer reviews, and participation in scientific forums. He is recognized for his analytical approach and evidence-based practice. His long-standing affiliation with reputed institutions and research groups underscores his strong leadership in oral surgery and academic scholarship.

Research Focus:

Dr. Ghorbani’s primary research interests lie in oral pathology, craniofacial surgery, dentoalveolar trauma, and radiological diagnostics. His work often combines clinical case reports with retrospective analysis, offering insights into rare presentations such as parathyroid carcinoma-linked jaw tumors, and developmental anomalies like concha bullosa. A hallmark of his research is his ability to identify atypical symptoms and connect them with broader systemic conditions, ensuring early diagnosis and management. He has conducted fractal analysis studies to evaluate bone quality, and he explores patient-centered outcomes, such as satisfaction post-rhinoplasty and the psychological impacts of facial surgery. Additionally, his research evaluates the intersection of dental surgery with systemic health—evident in studies related to auditory changes post-orthognathic surgery or the implications of COVID-19 on dental care. Through evidence-based methods and innovative case analyses, Dr. Ghorbani has positioned himself as a thought leader in interdisciplinary oral and maxillofacial research.

Publications Top Notes:

  1. Brown tumors of both jaws as the initial manifestation of parathyroid carcinoma (BMC Oral Health, 2025)

  2. Distribution and laterality of concha bullosa across cranial skeletal types (Maxillofacial Plastic Surg, 2025)

  3. Calcifying Odontogenic Cyst in Posterior Maxilla: A Case Report (Journal of Dentistry Shiraz, 2025)

  4. Central giant cell granuloma mimicking fibro-osseous lesion and hemangioma (J Med Case Reports, 2024)

  5. Fractal CT analysis of mandibular condyles in class III malocclusion (Scientific Reports, 2023)

  6. Patient dissatisfaction following rhinoplasty: A 10-year Iranian study (Maxillofacial Plastic Surg, 2023)

  7. Correlation between impacted third molar and blood group (Int J of Dentistry, 2021)

  8. Effects of orthognathic surgery on auditory function (Maxillofacial Plastic Surg, 2021)

  9. Evaluation of alveolar fractures in trauma patients in Iran (BMC Oral Health, 2021)

  10. Anxiety in patients undergoing mandibular third molar extraction (J Oral Research & Review, 2020)

Conclusion:

In summary, Dr. Farhad Ghorbani embodies the qualities of a deeply committed, analytically skilled, and academically active oral and maxillofacial surgeon. His research is directly informed by his clinical experience, allowing him to bridge theory and practice effectively. His contributions have enriched the literature on oral pathology, surgical complications, facial aesthetics, and patient psychology following treatment interventions. While there are opportunities to expand the scope and scale of his work through more robust methodologies and international collaboration, his existing portfolio already reflects a high standard of academic and clinical integration. Given his track record, ongoing research productivity, and evident commitment to innovation and education, Dr. Ghorbani is a strong and deserving candidate for the Best Researcher Award. With continued growth in research leadership and expanded global outreach, he is poised to make an even greater impact in the years ahead.

Chenlong YANG | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. Chenlong YANG | Cancer Cell Biology | Best Researcher Award

Prof. Chenlong YANG, Peking University Third Hospital, China

Dr. Chenlong Yang, M.D., Ph.D., is an accomplished neurosurgeon and research associate professor at the Department of Neurosurgery, Peking University Third Hospital. With over 15 years of clinical and research experience, he specializes in neuro-oncology, spinal neurosurgery, and translational neuroscience. Dr. Yang earned his M.D. from Shandong University and his Ph.D. in Neurological Surgery from Capital Medical University. He has trained and worked in prestigious institutions including Beijing Tiantan Hospital and the State Key Laboratory of Vascular Homeostasis and Remodeling. He has contributed significantly to advancements in brain tumor diagnostics, neuroimmunology, and surgical innovations, with numerous high-impact publications. Recognized internationally, he frequently presents at top neurosurgical conferences such as EANS and the Japan-China Neurosurgery Alliance. His research bridges basic science and clinical neurosurgery, aiming to improve surgical precision and therapeutic outcomes. Dr. Yang is also known for his leadership in collaborative, multidisciplinary research teams.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. 📚 Robust Academic and Clinical Training

    • Earned an M.D. from Shandong University and a Ph.D. in Neurological Surgery from Capital Medical University.

    • Completed clinical training at Beijing Tiantan Hospital, a top-tier neurosurgical institution in China.

  2. 🔬 Multidisciplinary and Translational Research Excellence

    • His research spans neuro-oncology, neuroimmunology, spinal neurosurgery, and advanced neuroimaging.

    • Conducted preclinical work on Alzheimer’s disease models and neuroprotection, along with current research in immune checkpoint therapy and intraoperative imaging.

  3. 📈 High-Impact Publications

    • Over 20 peer-reviewed publications in journals such as Scientific Reports, J Exp Clin Cancer Res, Neurosurgical Review, and Biophysical Journal.

    • His research on chordomas, gliomas, and spinal tumors has significantly contributed to the field.

  4. 🌍 International Recognition

    • Speaker at major international conferences like EANS 2025 and KSNS 2024.

    • Previously awarded a scholarship by the Turkish Neurosurgical Society.

  5. 🤝 Leadership in Collaboration

    • Plays a key role at the Center for Precision Neurosurgery and Oncology and the State Key Laboratory of Vascular Homeostasis and Remodeling, fostering interdisciplinary collaborations across neurosurgery, imaging, and immunotherapy.

  6. 🎯 Focus on Precision and Innovation

    • Pioneering high-resolution MRI techniques, fluorescent intraoperative navigation, and predictive modeling for neurosurgical outcomes.

🔄 Areas for Improvement:

  1. 📊 Independent Research Lead

    • While he has several corresponding author papers, increasing his share of first-author or sole-PI grants would further elevate his research identity.

  2. 🌐 Global Collaborations

    • Though he has spoken at international conferences, expanding collaborative projects with leading global neuroscience centers could amplify impact.

  3. 💡 Technology Commercialization

    • Given his innovation in imaging and diagnostics, pursuing intellectual property rights or translational funding (e.g., for clinical tools or surgical systems) could be a valuable next step.

  4. 📄 Diversification of Research Outputs

    • A few review articles and meta-analyses would strengthen his role as a thought leader and field synthesizer.

📘 Education:

Dr. Yang pursued his foundational medical education at Shandong University, earning an M.D. in Clinical Medicine (2006–2011). This training provided a solid clinical base and early exposure to neurology and internal medicine. He then advanced to a doctoral program at Capital Medical University, Beijing (2011–2017), earning his Ph.D. in Neurological Surgery. During his Ph.D., he received specialized training in neurosurgical techniques and engaged in cutting-edge research, particularly focusing on neuro-oncology and degenerative neural diseases. As part of his early research career, he also worked at the Institute of Neurobiology, Shandong University, investigating neuroprotective agents and Alzheimer’s disease models. Dr. Yang’s academic journey is characterized by rigorous clinical training and scientific inquiry, equipping him with the knowledge and skills essential for bridging the gap between the lab bench and the operating room. His education laid a strong foundation for his future contributions to precision neurosurgery and translational neuroscience.

💼 Experience:

Dr. Yang has over a decade of diversified experience across top medical and research institutions. He currently serves as a Research Associate Professor and Attending Physician at the Department of Neurosurgery, Peking University Third Hospital (2020–present), where he leads several clinical and translational research projects. Prior to this, he completed a postdoctoral fellowship (2017–2020) in the Department of Orthopedics at the same hospital, emphasizing spinal and neuro-oncologic conditions. From 2011 to 2017, he worked as a resident in Neurosurgery at Beijing Tiantan Hospital, one of China’s premier neurosurgical centers, gaining extensive experience in surgical treatments and neurovascular procedures. His roles span clinical surgery, research coordination, and academic instruction. Additionally, he actively contributes to the Center for Precision Neurosurgery and Oncology and the State Key Laboratory of Vascular Homeostasis and Remodeling, leading initiatives to improve patient outcomes through interdisciplinary innovations in neurosurgical care.

🧠 Research Focus:

Dr. Chenlong Yang’s research integrates neurosurgery, oncology, immunology, and biomedical engineering. His primary focus lies in neuro-oncology, with a strong emphasis on chordoma biology, glioma immunotherapy, and molecular diagnostics. He explores immune checkpoint therapies, tumor microenvironment modulation, and the development of predictive models for neurosurgical complications such as postoperative delirium. Dr. Yang is also deeply involved in technological innovation in neurosurgery, investigating intraoperative fluorescence imaging, high-resolution MRI, and minimally invasive spinal techniques. His work on spatial learning, Alzheimer’s models, and neuroprotection during his early career continues to inform his translational research. He collaborates across disciplines, from molecular biologists to radiologists, aiming to build precision-guided therapeutic frameworks. His research is extensively published in journals like Scientific Reports, J Exp Clin Cancer Res, and Frontiers in Neurology. Through this work, Dr. Yang seeks to advance the standard of care in neurosurgical oncology and promote patient-specific interventions.

📚 Publication Top Notes:

  1. 🧬 SMARCB1 orchestrates cellular plasticity and oncogenic pathways in typical and chondroid chordomas

  2. 🛡️ Cracking Chordoma’s Conundrum: Immune Checkpoints Provide a Potential Modality

  3. 🌱 From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms – a review

  4. 💡 Intraoperative fluorescence redefining neurosurgical precision

  5. 🧠 The evolution and integration of technology in spinal neurosurgery: A scoping review

  6. 👁️ Single-cell transcriptomic atlas of aging macaque ocular outflow tissues

  7. 🧮 Risk stratification and predictive modeling of postoperative delirium in chronic subdural hematoma

  8. 📶 Characteristic fingerprint spectrum of α-synuclein mutants on terahertz time-domain spectroscopy

  9. 🐒 Normative profile of retinal nerve fiber layer thickness in cynomolgus monkeys

  10. 🌀 Accurate diagnosis and treatment of sacral meningeal cysts using high-resolution MRI

  11. 🧪 Intraspinal hemangioblastomas: analysis of 92 cases in a single institution

🏁 Conclusion:

Dr. Chenlong Yang exemplifies the ideal profile of a cutting-edge clinician-scientist, merging neurosurgical precision with immunological insight and technological innovation. His commitment to patient-centered research, consistent academic output, and recognition on international platforms underscores his eligibility for the Best Researcher Award. With continued growth in independent leadership and global research impact, Dr. Yang is not only a deserving candidate now but is poised to become a prominent global figure in neurosurgical research in the years to come.

Huizheng Hu | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Ms. Huizheng Hu | Cancer Cell Biology | Best Researcher Award

Ms. Huizheng Hu , Nuclear Industry 215 Hospital of Shaanxi Province , China

Dr. Huizheng Hu is a distinguished medical scientist and Director of the Laboratory Department at the Nuclear Industry 215 Hospital of Shaanxi Province, China. As an Associate Professor, Dr. Hu has made significant strides in the fields of tumor cell biology and microbial drug resistance. With a strong foundation in pathogenic microbiology and translational medicine, he integrates clinical practice with cutting-edge laboratory research. He has published six SCI-indexed papers and received numerous accolades, including multiple awards from the Xianyang Science and Technology Progress Committee and recognition as an “Outstanding Individual of Shaanxi Province.” His leadership in research projects on papillary thyroid carcinoma (PTC) and ongoing collaborations with Northwest University further reflect his dedication to scientific advancement. Known for his innovation, expertise, and commitment to healthcare, Dr. Hu is a leading figure bridging oncology and infectious disease research.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Research Excellence:
    Dr. Hu has published six peer-reviewed SCI-indexed papers in the fields of oncology and microbiology—two globally significant research domains.

  2. Leadership in Research Projects:
    Currently leading three active research projects on papillary thyroid carcinoma (PTC) and has successfully secured six competitive research grants, reflecting his project management and funding acquisition capabilities.

  3. Innovative Interdisciplinary Work:
    His translational research bridges tumor biology and infectious diseases, an emerging and impactful cross-disciplinary niche in medical science.

  4. Recognized Expertise:
    Awarded multiple prestigious honors including:

    • Third Prize from the Nuclear Industry Geological Exploration Bureau

    • Seven awards from the Xianyang Science and Technology Progress Committee

    • Named a “Three-Five Talent” and “Outstanding Individual of Shaanxi Province”

  5. Academic Collaborations:
    Active collaboration with Professor Li Zheng’s team at Northwest University, showcasing a commitment to scientific cooperation.

🔧 Areas for Improvement:

  1. Global Visibility:
    While regionally recognized, Dr. Hu’s international presence could be enhanced by:

    • Publishing in higher-impact global journals

    • Participating in global scientific conferences or forums

  2. Editorial and Membership Roles:
    Expanding into editorial boards or joining professional organizations would further validate and amplify his professional stature in the scientific community.

  3. Digital/Research Profiles:
    Maintaining updated digital research profiles (e.g., Google Scholar, ResearchGate) and citation metrics would strengthen the transparency and accessibility of his academic output.

🎓 Education:

Dr. Huizheng Hu holds an advanced academic background specializing in medical sciences with a focus on tumor biology and microbiology. He earned his medical degree and pursued postgraduate training in pathogenic microbiology, acquiring both clinical and research experience. His academic training includes a strong emphasis on experimental design, molecular biology, and translational research. Dr. Hu further refined his expertise during specialized programs and workshops that focused on cancer biology, microbial resistance mechanisms, and diagnostic laboratory technologies. This rigorous educational foundation enabled him to become an expert in handling infectious disease diagnostics and tumor pathology. His education was also complemented by institutional mentorships and collaborations that contributed to his development as an academic and professional leader in his field. As an academic, he continues to integrate his theoretical training into real-world clinical scenarios, enhancing both patient outcomes and scientific understanding.

💼 Professional Experience:

With over a decade of experience in clinical and laboratory medicine, Dr. Huizheng Hu currently serves as the Director of the Laboratory Department at Nuclear Industry 215 Hospital in Shaanxi Province. As an Associate Professor, he has led various research initiatives and clinical programs, particularly in oncology and microbiology. His role involves overseeing diagnostics, laboratory quality control, and supervising research staff. Dr. Hu has been a key figure in managing multidisciplinary projects focused on tumor biology and microbial resistance. He has secured six competitive research grants and is actively involved in national and regional research programs. His accolades include multiple awards for scientific innovation and academic leadership, such as the “Leading Talent in Scientific and Technological Innovation” title. Dr. Hu has also been recognized for his contributions to public health and research excellence through provincial honors. His practical experience strengthens his role as both a healthcare provider and scientific innovator.

🔬 Research Focus:

Dr. Huizheng Hu’s research focuses on two core areas: tumor cell biology and microbial drug resistance mechanisms. His studies aim to understand the cellular and molecular dynamics of cancers, especially papillary thyroid carcinoma (PTC), and how microbial pathogens adapt to drugs in clinical settings. His translational research bridges oncology with infectious disease treatment, offering new perspectives on personalized medicine. Currently, Dr. Hu is leading three major projects targeting PTC progression and diagnostics. Additionally, he collaborates with Professor Li Zheng’s team at Northwest University to explore mechanisms of microbial resistance, with a particular emphasis on hospital-acquired infections. His work integrates clinical microbiology, molecular biology, and pathology, aiming to develop targeted therapies and improve diagnostic accuracy. Through extensive laboratory work, real-world clinical application, and collaborative research, Dr. Hu is actively contributing to both cancer and infectious disease innovation, striving for improved patient care outcomes and global health advancements.

📚 Publications Top Notes:

  • 🦠📊 Analysis of infection indicators and risk factors for influenza A after the COVID-19 pandemic – New Microbiologica, 2024

  • 🔬🧬 Molecular pathways in papillary thyroid carcinoma: A focus on tumor microenvironment interactions

  • 💊🧫 Mechanisms of microbial resistance to last-line antibiotics in hospital pathogens

  • 🧪👨‍⚕️ Diagnostic advancements in thyroid cancer: A laboratory-based approach

  • 🧻⚗️ The interplay between microbiota and immune modulation in cancer patients

  • 🧬🧪 Comparative study of PTC biomarkers using immunohistochemical techniques

🧾 Conclusion:

Dr. Huizheng Hu is a highly suitable candidate for the Best Researcher Award. His leadership in research, strong publication record, and numerous regional accolades demonstrate sustained excellence in scientific innovation. While expanding international engagement could further elevate his profile, his ongoing contributions to cancer and microbiology research already reflect a distinguished career deserving of recognition at a global level.